4 years ago
MRNA
AnalystsMani ForooharMani Foroohar's Stock Forecasts
AnalystsMani Foroohar
Analyst Ranking
Bottom 2%
#5034 out of 5134 analysts
Average Return
-6.55%
Win Rate
44%54 out of 123
Risk vs Reward
Poor
Good
Mani Foroohar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Bridgebio Pharma IncBBIO | +346.48% | $8.52 | $38.04 | 2023-01-23 - 2024-01-22 | Buy |
Lexeo Therapeutics IncLXEO | +255.51% | $2.63 | $9.35 | 2025-05-12 - 2025-12-05 | Buy |
Bridgebio Pharma IncBBIO | +250.59% | $9.29 | $32.57 | 2022-07-26 - 2023-07-25 | Buy |
Wave Life Sciences LtdWVE | +163.38% | $4.97 | $13.09 | 2023-12-19 - 2024-12-18 | Buy |
Lexeo Therapeutics IncLXEO | +128.61% | $4.09 | $9.35 | 2025-03-24 - 2025-12-05 | Buy |
Mani Foroohar Analyst Color
Get additional color on Mani Foroohar's coverage of popular stocks
Mani Foroohar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Moderna IncMRNA | 18 | Sell | $18.00 | -35.02% | Maintains | 17 days ago |
Lexeo Therapeutics IncLXEO | 6 | Buy | $20.00 | +113.90% | Maintains | 2 months ago |
Rocket Pharmaceuticals IncRCKT | 13 | Hold | $7.00 | +110.84% | Maintains | 2 months ago |
Sarepta Therapeutics IncSRPT | 2 | Hold | $10.00 | -55.08% | Downgrades | 5 months ago |
Recursion Pharmaceuticals IncRXRX | 8 | Hold | $6.00 | +27.39% | Maintains | 9 months ago |
4d Molecular Therapeutics IncFDMT | 9 | Buy | $27.00 | +152.34% | Maintains | a year ago |
Neurogene IncNGNE | 2 | Buy | $72.00 | N/A | Maintains | a year ago |
Camp4 Therapeutics CorpCAMP | 1 | Buy | $17.00 | N/A | Initiates Coverage On | a year ago |
Mirum Pharmaceuticals IncMIRM | 11 | Buy | $49.00 | N/A | Maintains | a year ago |
Bridgebio Pharma IncBBIO | 12 | Buy | $46.00 | N/A | Maintains | a year ago |
Wave Life Sciences LtdWVE | 5 | Buy | $22.00 | N/A | Maintains | a year ago |
Ionis Pharmaceuticals IncIONS | 12 | Buy | $62.00 | N/A | Upgrades | a year ago |
Benitec Biopharma IncBNTC | 1 | Buy | $13.00 | N/A | Initiates Coverage On | a year ago |
Schrodinger IncSDGR | 1 | Buy | $29.00 | N/A | Initiates Coverage On | a year ago |
Curevac NvCVAC | 2 | Hold | $4.00 | N/A | Downgrades | 2 years ago |
Engene Holdings IncENGN | 1 | Buy | $31.00 | N/A | Initiates Coverage On | 2 years ago |
Kalaris Therapeutics IncKLRS | 10 | Hold | $23.00 | N/A | Downgrades | 2 years ago |
Tenaya Therapeutics IncTNYA | 1 | Buy | $7.00 | N/A | Initiates Coverage On | 2 years ago |
Arrowhead Pharmaceuticals IncARWR | 10 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Decibel Therapeutics IncDBTX | 5 | Hold | $2.00 | N/A | Downgrades | 3 years ago |
Regenxbio IncRGNX | 6 | Hold | $14.00 | N/A | Maintains | 3 years ago |
Intellia Therapeutics IncNTLA | 4 | Buy | $84.00 | N/A | Maintains | 3 years ago |
Editas Medicine IncEDIT | 4 | Hold | $7.00 | N/A | Maintains | 3 years ago |
Bluebird Bio IncBLUE | 10 | Hold | $160.00 | N/A | Maintains | 3 years ago |
Beam Therapeutics IncBEAM | 2 | Buy | $77.00 | N/A | Maintains | 3 years ago |
Alnylam Pharmaceuticals IncALNY | 8 | Hold | $143.00 | N/A | Maintains | 3 years ago |
Amryt Pharma PLCAMYT | 6 | Hold | $14.50 | N/A | Downgrades | 3 years ago |
Lenz Therapeutics IncLENZ | 4 | Hold | $2.00 | N/A | Downgrades | 3 years ago |
Abeona Therapeutics IncABEO | 5 | Hold | $6.00 | N/A | Maintains | 3 years ago |
Crispr Therapeutics AgCRSP | 1 | Buy | $76.00 | N/A | Maintains | 3 years ago |
Tourmaline Bio IncTRML | 5 | Hold | $2.00 | N/A | Maintains | 3 years ago |
Caribou Biosciences IncCRBU | 4 | Buy | $34.00 | N/A | Maintains | 4 years ago |
Sio Gene Therapies IncSIOX | 2 | Hold | $1.00 | N/A | Downgrades | 4 years ago |
Dicerna Pharmaceuticals IncDRNA | 4 | Buy | $47.00 | N/A | Maintains | 4 years ago |
Adverum Biotechnologies IncADVM | 6 | Hold | $20.00 | N/A | Maintains | 4 years ago |
Tectonic Therapeutic IncTECX | 1 | Hold | $120.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.